Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23) (2017)
- Authors:
- USP affiliated authors: SARTORI, ANA MARLI CHRISTOVAM - FM ; SOÁREZ, PATRÍCIA COELHO DE - FM ; NOVAES, HILLEGONDA MARIA DUTILH - FM
- Unidade: FM
- Subjects: REVISÃO SISTEMÁTICA; IDOSOS; VACINAÇÃO; CUSTOS DOS CUIDADOS DE SAÚDE
- Language: Inglês
- Imprenta:
- Source:
- Título: Value in health
- ISSN: 1098-3015
- Volume/Número/Paginação/Ano: v. 20, n. 5, p. A932-A932, 2017
- Conference titles: ISPOR Annual international meeting
-
ABNT
NISHIKAWA, A. M et al. Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23). Value in health. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 26 jan. 2026. , 2017 -
APA
Nishikawa, A. M., Mainardi, G. M., Novaes, H. M. D., Sartori, A. M. C., & Soarez, P. C. de. (2017). Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23). Value in health. New York: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Nishikawa AM, Mainardi GM, Novaes HMD, Sartori AMC, Soarez PC de. Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23). Value in health. 2017 ; 20( 5): A932-A932.[citado 2026 jan. 26 ] -
Vancouver
Nishikawa AM, Mainardi GM, Novaes HMD, Sartori AMC, Soarez PC de. Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23). Value in health. 2017 ; 20( 5): A932-A932.[citado 2026 jan. 26 ] - Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older
- Revisão sistemática das diretrizes de análise de impacto
- Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil
- Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil
- Vaccines are different: A systematic review of budget impact analyses of vaccines
- Polio inactivated vaccine costs into routine childhood immunization in Brazil
- Methods and challenges for the health impact assessment of vaccination programs in Latin America
- Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil
- Economic evaluation of adolescents and adults' pertussis vaccination: a systematic review of current strategies
- Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
